AVITA Medical (RCEL) Common Equity (2018 - 2026)
AVITA Medical's (RCEL) quarterly Common Equity came in at -$16.6 million in Q4 2025, down 470.08% YoY from $4.5 million in Q4 2024, and down 149.77% on a QoQ basis from -$6.7 million in Q3 2025.
AVITA Medical (RCEL) Common Equity (2018 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 8 years of Common Equity data on file, last reported at -$16.6 million in Q4 2025.
- Quarterly Common Equity fell 470.08% year-over-year to -$16.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$16.6 million (down 470.08% YoY) and the FY2025 annual result came in at -$16.6 million, down 470.08% from the prior year.
- Common Equity eased to -$16.6 million in Q4 2025, from -$6.7 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $118.9 million in Q1 2021 to a low of -$16.6 million in Q4 2025.
- A 5-year average of $55.2 million and a median of $65.8 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2021 — Common Equity soared 75.55% — and 2025, when it sank 470.08%.
- Tracing RCEL's Common Equity over 5 years: stood at $104.6 million in 2021, then slipped by 19.01% to $84.7 million in 2022, then tumbled by 42.11% to $49.1 million in 2023, then slumped by 90.83% to $4.5 million in 2024, then slumped by 470.08% to -$16.6 million in 2025.
- The last three Common Equity figures came in at -$16.6 million (Q4 2025), -$6.7 million (Q3 2025), and -$12.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 7.22 Bn |
| 10 | AVITA Medical | 309.04 Mn | 297.90 Mn | 17.77 Mn | -27.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.84 Mn |
| Dec 31, 2025 | -16.65 Mn |
| Sep 30, 2025 | -6.67 Mn |
| Jun 30, 2025 | -12.89 Mn |
| Mar 31, 2025 | -4.57 Mn |
| Dec 31, 2024 | 4.50 Mn |
| Sep 30, 2024 | 12.23 Mn |
| Jun 30, 2024 | 23.92 Mn |
| Mar 31, 2024 | 32.57 Mn |
| Dec 31, 2023 | 49.06 Mn |
| Sep 30, 2023 | 62.98 Mn |
| Jun 30, 2023 | 68.65 Mn |
| Mar 31, 2023 | 77.56 Mn |
| Dec 31, 2022 | 84.74 Mn |
| Sep 30, 2022 | 87.99 Mn |
| Jun 30, 2022 | 92.56 Mn |
| Mar 31, 2022 | 97.82 Mn |
| Dec 31, 2021 | 104.62 Mn |
| Sep 30, 2021 | 111.49 Mn |
| Jun 30, 2021 | 115.66 Mn |